MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
˜The œLancet. Gastroenterology & hepatology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

205 results · 1 filter active ·
Results by year
20162025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
205 works in the cohort · of 4,299,418page 1 of 5

Labels cover 0 of 205 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 205 of 205 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
A global scientific strategy to cure hepatitis B
Peter Revill, Francis V. Chisari, Joan M. Block, Maura Dandri, Adam J. Gehring, Haitao Guo +45 more
2019· article· en· ˜The œLancet. Gastroenterology & hepatology· Medicine
machine prediction:candidate · noneconsensus · none
495
citations
affaboutunlabeled
Global burden of inflammatory bowel disease
Vipul Jairath, Brian G. Feagan
2019· letter· en· ˜The œLancet. Gastroenterology & hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
363
citations
affno abstractunlabeled
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
Brian G. Feagan, Bruce E. Sands, William J. Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao +57 more
2023· article· en· ˜The œLancet. Gastroenterology & hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
224
citations
affno abstractunlabeled
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
Ashwin N. Ananthakrishnan, Gilaad G. Kaplan, Çharles N. Bernstein, Kristin E. Burke, Paul Lochhead, Alexa N. Sasson +10 more
2022· review· en· ˜The œLancet. Gastroenterology & hepatology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
149
citations

How this was built: Screen · Findings · About